Intellectual property, drug licensing, freedom of information, and public health

Lancet. 1998 Aug 29;352(9129):726-9. doi: 10.1016/S0140-6736(98)07600-4.
No abstract available

MeSH terms

  • Albumins / therapeutic use
  • Clinical Trials as Topic
  • Communication
  • Drug Approval* / legislation & jurisprudence
  • Drug Industry*
  • Government Agencies
  • Humans
  • Intellectual Property*
  • Public Health
  • United Kingdom

Substances

  • Albumins